Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients.
Sarah K L MooreKatherine H ChauSalma ChaudharyGeoffrey RubinJoseph BayneUma Mahesh R AvulaDaniel Y WangCarmine SorberaJose DizonAngelo BivianoMarc WaaseVivek IyerIsaac GeorgeSusheel K KodaliTamim M NazifHasan GaranElaine Y WanPublished in: Pacing and clinical electrophysiology : PACE (2019)
In this small retrospective study, LPMs were feasible post-THVR and found to perform as well as SCPs, had less intraprocedural blood loss, and were associated with less tricuspid regurgitation. Further, larger studies are required to follow longer-term outcomes and complications.
Keyphrases
- aortic valve
- aortic stenosis
- ejection fraction
- end stage renal disease
- mitral valve
- newly diagnosed
- chronic kidney disease
- heart failure
- transcatheter aortic valve replacement
- prognostic factors
- risk factors
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- adipose tissue
- insulin resistance
- left ventricular
- skeletal muscle